India

Since the emergence of COVID-19, clearly communicating dos and don'ts to audiences who live and work in low resource and crowded contexts has become more important than ever. As the pandemic progresses, the need for physical distancing, masks, and hand-washing will remain for the foreseeable future.

In 2016, Solidarity and Action Against the HIV Infection in India began a partnership with Janssen Global Public Health, an initiative of the Janssen Pharmaceutical Companies of Johnson & Johnson. The initiative, named m-Maitri, aimed to complement on-the-ground efforts at ensuring retention in the prevention of parent-to-child transmission cascade with interactive voice response (IVR) to consenting pregnant women and mother-baby pairs until the babies reach 18 months of age.

 

TB is second only to HIV as a killer infectious disease, with more than 10 million new infections in 2015 and an estimated 1.8 million deaths mostly in low- and middle-income countries.In many countries, the private sector represents a major and growing source of services for suspected and active cases of TB. This often presents a challenge for national health systems that are ill-equipped to ensure that private providers provide safe and effective care.

As a follow up to the India Newborn Action Plan, the Haryana Newborn Action Plan (HNAP) has been drafted as a state-specific roadmap for reducing preventable newborn deaths and stillbirths and achieving the desired targets for the neonatal mortality rate (NMR) and stillbirth rate (SBR) by 2030.

Pages